Flagship Harbor Advisors, LLC Eli Lilly & CO Transaction History

Flagship Harbor Advisors, LLC

$1.74 Billion
Q3 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 6,912 shares of LLY stock, worth $5.43 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

6,912

Previous 6,467 6.88%

Holding current value

$5.43 Million

Previous $5.03 Million 21.71%

% of portfolio

0.35%

Previous 0.33%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $343,602 - $427,208	445 Added 6.88%	6,912 $6.12 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $354,727 - $474,575	599 Added 10.21%	6,467 $5.03 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $317,739 - $374,573	605 Added 11.5%	5,868 $3.42 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $5,651 - $7,790	-13 Reduced 0.25%	5,263 $2.83 Million
Q2 2023 Jul 11, 2023	BUY	$350.74 - $468.98 $271,122 - $362,521	773 Added 17.17%	5,276 $2.47 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $249,746 - $293,315	804 Added 21.74%	4,503 $1.55 Million
Q4 2022 Jan 13, 2023	SELL	$321.55 - $374.67 $28,617 - $33,345	-89 Reduced 2.35%	3,699 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $82,717 - $94,265	-279 Reduced 6.86%	3,788 $1.23 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $61,041 - $71,672	-219 Reduced 5.11%	4,067 $1.32 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $51,162 - $63,581	218 Added 5.36%	4,286 $1.23 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $68,354 - $84,828	304 Added 8.08%	4,068 $1.12 Million
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $18,596 - $24,054	103 Added 2.81%	3,764 $864,000
Q1 2021 May 03, 2021	BUY	$164.32 - $212.72 $68,357 - $88,491	416 Added 12.82%	3,661 $684,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $29,875 - $39,532	229 Added 7.59%	3,245 $548,000
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $31,437 - $36,362	215 Added 7.68%	3,016 $446,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $30,830 - $37,104	226 Added 8.78%	2,801 $459,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $102,740 - $127,163	-863 Reduced 25.1%	2,575 $357,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $11,975 - $14,832	-112 Reduced 3.15%	3,438 $452,000
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $25,949 - $28,226	-243 Reduced 6.41%	3,550 $397,000
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $73,121 - $85,351	660 Added 21.07%	3,793 $420,000
Q1 2019 Apr 15, 2019	BUY	$111.31 - $131.02 $123,442 - $145,301	1,109 Added 54.79%	3,133 $406,000
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $14,296 - $16,016	-135 Reduced 6.25%	2,024 $234,000
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $343 - $429	4 Added 0.19%	2,159 $232,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $163,133 - $187,226	2,155 New	2,155 $183,000

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Eli Lilly & CO Transaction History